ATEMWEGSTHERAPIEGERÄT

European patent · EP4175703 · In force

Register entry

Publication number
EP4175703
Application number
EP21722237
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 3, 2021
Published
May 10, 2023
Granted
Oct 2, 2024
Protection ends at the latest
May 2, 2041
Next annual fee due
May 31, 2027
IPC classes
A63B 21/00 (2006.01)
A63B 23/18 (2006.01)
A61M 16/00 (2006.01)
A61M 16/20 (2006.01)
A61M 16/08 (2006.01)
A63B 71/06 (2006.01)
Priority
EP 20190395 11.08.2020
PCT application
PCT/EP2021/061531 03.05.2021
PCT publication
WO2022/033734 17.02.2022
Filing language
German
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Aug 13, 2025

    Change

    Published in Swissreg on 13.08.2025

  3. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  4. Oct 18, 2024

    Agent entered

    Representative
    Geitz Patentanwälte PartG mbB, Obere Wässere 3-7, 72764 Reutlingen, Germany

    Published in Swissreg on 18.10.2024

  5. Oct 3, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 03.10.2024

Parties

Holder

CEGLA Medizintechnik GmbH

Horresser Berg 1, 56410 Montabaur, DE

Agent

Geitz Patentanwälte PartG mbB

Obere Wässere 3-7, 72764 Reutlingen, DE

Inventor

EBINGER, Andrea

56410 Montabaur, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.